Advertisement

Lung

, Volume 188, Issue 5, pp 365–373 | Cite as

Combined Pulmonary Fibrosis and Emphysema Alters Physiology but Has Similar Mortality to Pulmonary Fibrosis Without Emphysema

  • Matthew D. JankowichEmail author
  • Sharon Rounds
Article

Abstract

Studies have described individuals with combined pulmonary fibrosis and emphysema (CPFE), with preserved lung volumes, significant reductions in gas exchange, and high prevalence of pulmonary hypertension. While physiologic changes in CPFE are well documented, there is little mortality data in the CPFE population compared to appropriate controls. A study was performed to determine the features and outcomes of a group of individuals with imaging and/or pathologic evidence of CPFE to determine if individuals with combined pulmonary fibrosis and emphysema have different features and survival than individuals with pulmonary fibrosis alone. We conducted a retrospective study at a Veterans Affairs Medical Center. Included in the study were individuals hospitalized over a 5-year period who were given a clinical diagnosis of pulmonary fibrosis. Individuals with confirmed imaging or pathologic evidence of pulmonary fibrosis were divided into a study group with concomitant emphysema (CPFE group, n = 20) and a control group without emphysema (isolated pulmonary fibrosis (PF) group, n = 24). The CPFE group, all current or former cigarette smokers, had significantly larger lung volumes, more expiratory airflow obstruction, and worse gas exchange than the isolated pulmonary fibrosis group. Mortality did not differ between the groups. Combined pulmonary fibrosis and emphysema results in unique physiologic features but no difference in survival compared with a group with pulmonary fibrosis alone.

Keywords

Combined pulmonary fibrosis and emphysema Idiopathic pulmonary fibrosis Emphysema 

Notes

Acknowledgments

This publication is the result of work supported with resources and facilities from the Providence VA Medical Center and was supported in part by HL 64936 from the National Heart Lung Blood Institute.

Conflicts of interest statement

None.

References

  1. 1.
    Wiggins J, Strickland B, Turner-Warwick M (1990) Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment. Respir Med 84:365–369CrossRefPubMedGoogle Scholar
  2. 2.
    Cottin V, Nunes H, Brillet PY, Delaval P, Devouassoux G, Tillie-Leblond I, Israel-Biet D, Court-Fortune I, Valeyre D, Cordier JF, the Groupe d’Etude et de Recherche sur les Maladies “Orphelines” Pulmonaires (GERM“O”P) (2005) Combined pulmonary fibrosis and emphysema: a distinct underrecognized entity. Eur Respir J 26:586–593CrossRefPubMedGoogle Scholar
  3. 3.
    Mejía M, Carrillo G, Rojas-Serrano J, Estrada A, Suárez T, Alonso D, Barrientos E, Gaxiola M, Navarro C, Selman M (2009) Idiopathic pulmonary fibrosis and emphysema. Chest 136:10–15CrossRefPubMedGoogle Scholar
  4. 4.
    Cottin V, Cordier JF (2009) The syndrome of combined pulmonary fibrosis and emphysema. Chest 136:1–2CrossRefPubMedGoogle Scholar
  5. 5.
    Jankowich MD, Polsky M, Klein M, Rounds S (2008) Heterogeneity in combined pulmonary fibrosis and emphysema. Respiration 75:411–417CrossRefPubMedGoogle Scholar
  6. 6.
    Grubstein A, Bendayan D, Schactman I, Cohen M, Shitrit D, Kramer MR (2005) Concomitant upper-lobe bullous emphysema, lower lobe interstitial fibrosis, and pulmonary hypertension in heavy smokers: report of eight cases and review of the literature. Respir Med 99:948–954CrossRefPubMedGoogle Scholar
  7. 7.
    Akagi T, Matsumoto T, Harada T, Tanaka M, Kuraki T, Fujita M, Watanabe K (2009) Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis. Respir Med 103:1209–1215CrossRefPubMedGoogle Scholar
  8. 8.
    Doherty MJ, Pearson MG, O’Grady EA, Pellegrini V, Calverley PM (1997) Cryptogenic fibrosing alveolitis with preserved lung volumes. Thorax 52:998–1002CrossRefPubMedGoogle Scholar
  9. 9.
    Niewoehner DE, Hoidal JR (1982) Lung fibrosis and emphysema: divergent responses to a common injury. Science 217:359–360CrossRefPubMedGoogle Scholar
  10. 10.
    Lang MR, Fiaux GW, Gillooly M, Stewart JA, Hulmes DJ, Lamb D (1994) Collagen content of alveolar wall tissue in emphysematous and non-emphysematous lungs. Thorax 49:319–326CrossRefPubMedGoogle Scholar
  11. 11.
    King TE Jr, Tooze JA, Schwarz MI, Brown KR, Cherniack RM (2001) Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 164:1171–1181PubMedGoogle Scholar
  12. 12.
    Antoniou KM, Hansell DM, Rubens MB, Marten K, Desai SR, Siafakas NM, Nicholson AG, du Bois RM, Wells AU (2008) Idiopathic pulmonary fibrosis: outcome in relation to smoking status. Am J Respir Crit Care Med 177:190–194CrossRefPubMedGoogle Scholar
  13. 13.
    Collard HR, King TE Jr, Bartelson BB, Vourlekis JS, Schwarz MI, Brown KK (2003) Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 168:538–542CrossRefPubMedGoogle Scholar
  14. 14.
    Katzenstein AL, Mukhopadhyay S, Myers JL (2008) Diagnosis of usual interstitial pneumonia and distinction from other fibrosing interstitial lung diseases. Hum Pathol 39:1275–1294CrossRefPubMedGoogle Scholar
  15. 15.
    Yousem SA (2006) Respiratory bronchiolitis-associated interstitial lung disease with fibrosis is a lesion distinct from fibrotic nonspecific interstitial pneumonia: a proposal. Mod Pathol 19:1474–1479PubMedGoogle Scholar
  16. 16.
    Attili AK, Kazerooni EA, Gross BH, Flaherty KR, Myers JL, Martinez FJ (2008) Smoking-related interstitial lung disease: radiologic-clinical-pathologic correlation. Radiographics 28:1383–1398CrossRefPubMedGoogle Scholar
  17. 17.
    Papadopoulos CE, Pitsiou G, Karamitsos TD, Karvounis HI, Kontakiotis T, Giannakoulas G, Efthimiadis GK, Argyropoulou P, Parharidis GE, Bouros D (2008) Left ventricular diastolic dysfunction in idiopathic pulmonary fibrosis: a tissue Doppler echocardiographic study. Eur Respir J 31:701–706CrossRefPubMedGoogle Scholar
  18. 18.
    Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing Z-C, Krowka MJ, Langleben D, Nakanishi N, Souza R (2009) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 54:S43–S54CrossRefPubMedGoogle Scholar
  19. 19.
    O’Donnell CR, Bankier AA, Stiebellehner L, Reilly JJ, Brown R, Loring SH (2010) Comparison of plethysmographic and helium dilution lung volumes: which is best for COPD? Chest 137:1108–1115CrossRefPubMedGoogle Scholar
  20. 20.
    Newell JD Jr (2008) Quantitative computed tomography of lung parenchyma in chronic obstructive pulmonary disease: an overview. Proc Am Thorac Soc 5:915–918CrossRefPubMedGoogle Scholar

Copyright information

© US Government 2010

Authors and Affiliations

  1. 1.Vascular Research LaboratoryProvidence VA Medical CenterProvidenceUSA
  2. 2.Division of Pulmonary, Critical Care, and Sleep Medicine, Department of MedicineAlpert Medical School of Brown UniversityProvidenceUSA

Personalised recommendations